first swiss israel investment summit in medical …€¦ · hotel st. gotthard, bahnhofstrasse 87,...
TRANSCRIPT
FIRST SWISS ISRAEL INVESTMENT SUMMIT IN MEDICAL CANNABIS
Thursday, 31st January 201910:00 – 19:00
Hotel St. Gotthard, Bahnhofstrasse 87, 8001 Zurich
Handelskammer Schweiz – Israel, Postfach 1564, 8027 ZürichTEL 044 362 16 30 | [email protected] | www.swissisrael.ch
Rodin Aeschbach Founder & CEO of Pharmotech SA Switzerland
Adv. Inbal Faibish Wassmer Partner, ROSAK - Rosenberg Abramovich Keren-Polak & Co., Advocates
Anand Shahi CEO of Bar Capital, Israel
Dr. Hadar Less CEO of Cannika & co-founder Yarok Medtech Israel
Dr. Daniela Eigenmann Pharmacist, Apotheke Langnau i.E., Swiss pharmacy selling medical cannabis
Prof. Simon Benita, PhD Head laboratory of Nano Delivery Systems at Cannabinoids Research Multidisciplinary Center, Hebrew University Israel
Saul Kaye CEO, iCAN Israel, advisor to medical cannabis commitee of the Knesset
Mr. Jacob Keidar Ambassador of the State of Israel to Switzerland
Dr. Inbar Maymon Pomeranchik Scientific Due Diligence Expert, specializing in global medical cannabis, Israel
Dr. Jonathan Grunfel Neurologist, palliative care, Asaf Harofeh Medical Center, Israel
Irit Avisar President, co-founder Israel Medical Cananabis Nursing Association
Bea Goldman CEO Medcanned, intensive care specialist ALS nurse, Switzerland
Margrit Kessler Member of Swiss Parlament 2011 - 2015, initiated motion for medical cannabis
Daniel Gutenberg General Partner at VI Partners AG Switzerland, business angel and investor
Prof. Eli Alon M.D. Professor of Anesthesiology and pain medicine University of Zurich. Director Interdisciplinary pain control unit
Dr. Miri Halperin Wernli CEO Creso Pharma Switzerland
Daniel Furman Founder & Managing Director of ARBA Finance Company, Israel
Laura Herschlag COO of Cannika & co-founder of Yarok Medtech Ltd., Israel
Dr. Catherine Ritter Federal office of public health, Berne
Our speakers
Handelskammer Schweiz-IsraelChambre de Commerce Suisse-IsraëlChamber of Commerce Switzerland-Israel
Our sponsorsSWISS FRIENDS OF
Welcome to the first Swiss-Israel Medical Cannabis Invest-ment Summit focused on investing in Israel’s medical canna-bis innovation.
Supported by Innosuisse and supervised by federal office of public health BAG.
Medical cannabis is one of the fastest growing emerging industries of the 21st century. Switzerland prepares for the legalization of medical cannabis. This timely event introduc-es Israel’s world leading medical cannabis ecosystem. It offers opportunities for collaboration to doctors, people from MedCann manufacturing and pharmaceutical indus-tries, Swiss investors, business people, and scientific com-munity.
Join us to learn about:
• How scientists and researchers from world renown institutions are creating the future of cannabinoid medicine
• Clinical trials on cannabinoid based treatments in progress in Israel’s leading hospitals
• Medical experience of doctors, carers and patients with cannabinoid medicine in Israel and Switzerland
• Attractive investment opportunities in Israel’s medical cannabis industry
• Public and private endeavors to foster technology innovation in agricultural, processing, production, and medical technologies
AGENDA
Registration: e-mail to [email protected] to Post-Finance 80-32379-6IBAN CH47 0900 0000 8003 2379 6No refund
Handelskammer Schweiz-IsraelChambre de Commerce Suisse-IsraëlChamber of Commerce Switzerland-Israel
Entry fee including luncheon:CHF 120 for member of the Chamber of Commerce Switzerland IsraelCHF 160 for non-member (early birds until 31st December 2018: CHF 120)
Registration & coffee 09:00
Legal and Regulatory Environment 10:00
Opportunities in New Technology and Pharmaceuticals, Panel 10:40
Lunch break 12:20
Israel’s government approach vis-à-vis MedCann; 13:05
Investing in Israeli Medical Cannabis Companies, Panel 1 3 : 1 5
The Medical Experience 1 4 : 1 5
Coffee break 15:35
The Medical Experience, Panel 15:50
Pitch session with Israeli MedCann startups 16:20
Reception and Networking 17:30
For detailed program and speakers’ list: www.canninvest.ch